FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE
FDA is a Ligand Of Interest in 4MOJ designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 4MOJ_FDA_A_801 | 99% | 15% | 0.047 | 0.981 | 1.53 | 2.25 | 6 | 17 | 0 | 0 | 100% | 1 |
| 4MOJ_FDA_D_801 | 99% | 16% | 0.047 | 0.981 | 1.44 | 2.22 | 10 | 17 | 2 | 0 | 100% | 1 |
| 4MOJ_FDA_B_702 | 99% | 11% | 0.047 | 0.98 | 1.88 | 2.35 | 9 | 20 | 2 | 0 | 100% | 1 |
| 4MOJ_FDA_C_801 | 96% | 15% | 0.06 | 0.971 | 1.49 | 2.3 | 14 | 16 | 2 | 0 | 100% | 1 |
| 4MOR_FDA_B_801 | 100% | 15% | 0.037 | 0.989 | 1.83 | 1.96 | 12 | 19 | 1 | 0 | 100% | 1 |
| 4MOQ_FDA_A_801 | 100% | 16% | 0.039 | 0.985 | 1.67 | 1.99 | 11 | 18 | 1 | 0 | 100% | 1 |
| 4MOF_FDA_A_801 | 100% | 19% | 0.04 | 0.983 | 1.62 | 1.84 | 14 | 15 | 1 | 0 | 100% | 1 |
| 4MOS_FDA_A_801 | 100% | 16% | 0.041 | 0.983 | 1.65 | 2 | 10 | 15 | 5 | 0 | 100% | 1 |
| 4MOO_FDA_A_801 | 100% | 24% | 0.041 | 0.982 | 1.42 | 1.67 | 7 | 14 | 2 | 0 | 100% | 1 |
| 4OPD_FDA_B_501 | 100% | 67% | 0.02 | 0.995 | 0.55 | 0.71 | - | 1 | 4 | 0 | 100% | 1 |
| 3UKF_FDA_B_600 | 100% | 10% | 0.027 | 0.995 | 2.22 | 2.05 | 19 | 19 | 2 | 0 | 100% | 1 |
| 3TSH_FDA_A_601 | 100% | 38% | 0.04 | 0.992 | 1.03 | 1.38 | 3 | 6 | 3 | 0 | 100% | 1 |
| 4OPC_FDA_A_501 | 100% | 64% | 0.038 | 0.986 | 0.6 | 0.76 | - | 2 | 1 | 0 | 100% | 1 |
| 3ATR_FDA_A_501 | 100% | 23% | 0.039 | 0.986 | 1.34 | 1.81 | 5 | 16 | 3 | 0 | 100% | 1 |
